CYTK vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CYTK

62.2
AI Score
VS
CYTK Wins

BBIO

41.1
AI Score

Investment Advisor Scores

CYTK

62score
Recommendation
HOLD

BBIO

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CYTK BBIO Winner
Forward P/E 117.6471 0 Tie
PEG Ratio -0.42 0 Tie
Revenue Growth 2356.5% 192.6% CYTK
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 62.2/100 41.1/100 CYTK
Profit Margin 0.0% -59.8% CYTK
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CYTK 1M: -10.5% · 3M: -25.7% BBIO 1M: +19.7% · 3M: -6.2%

Current Technical Phase

CYTK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 36

RSI (14): 35.8 · Price: $56.18

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.3 · Price: $78.67

Fundamentals Snapshot

Metric CYTK BBIO
Market Cap — —
Forward P/E -13.2 -287.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 23.6% 1.9%
Gross Margin -2.6% 0.9%
Operating Margin -3.5% 0.0%
EPS -6.02 -3.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CYTK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.